IDEAYA Biosciences (IDYA) Cash & Current Investments: 2019-2025
Historic Cash & Current Investments for IDEAYA Biosciences (IDYA) over the last 7 years, with Sep 2025 value amounting to $786.9 million.
- IDEAYA Biosciences' Cash & Current Investments fell 14.47% to $786.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year decrease of 0.71%. This contributed to the annual value of $676.3 million for FY2024, which is 28.79% up from last year.
- IDEAYA Biosciences' Cash & Current Investments amounted to $786.9 million in Q3 2025, which was up 17.49% from $669.7 million recorded in Q2 2025.
- Over the past 5 years, IDEAYA Biosciences' Cash & Current Investments peaked at $920.0 million during Q3 2024, and registered a low of $246.8 million during Q4 2021.
- Its 3-year average for Cash & Current Investments is $633.9 million, with a median of $676.3 million in 2024.
- In the last 5 years, IDEAYA Biosciences' Cash & Current Investments surged by 244.08% in 2021 and then dropped by 16.45% in 2022.
- IDEAYA Biosciences' Cash & Current Investments (Quarterly) stood at $246.8 million in 2021, then skyrocketed by 47.84% to $364.8 million in 2022, then spiked by 43.93% to $525.1 million in 2023, then increased by 28.79% to $676.3 million in 2024, then fell by 14.47% to $786.9 million in 2025.
- Its Cash & Current Investments was $786.9 million in Q3 2025, compared to $669.7 million in Q2 2025 and $692.5 million in Q1 2025.